Higher Trough Vedolizumab Concentrations During Maintenance Therapy are Associated With Corticosteroid-Free Remission in Inflammatory Bowel Disease

BACKGROUND AND AIMS: Vedolizumab is an anti-α4β7 biologic approved for ulcerative colitis [UC] and Crohn’s disease [CD]. We aimed to examine the association of maintenance vedolizumab concentrations with remission. METHODS: We performed a cross-sectional multi-centre study of inflammatory bowel dise...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:J Crohns Colitis
Main Authors: Ungaro, Ryan C, Yarur, Andres, Jossen, Jacqueline, Phan, Becky L, Chefitz, Ezra, Sehgal, Priya, Kamal, Kanika, Bruss, Alexandra, Beniwal-Patel, Poonam, Fox, Caroline, Patel, Amir, Bahur, Bayda, Jain, Anjali, Stein, Daniel, Naik, Snehal, Dubinsky, Marla C
פורמט: Artigo
שפה:Inglês
יצא לאור: Oxford University Press 2019
נושאים:
Original Articles
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC7185193/
https://ncbi.nlm.nih.gov/pubmed/31087100
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ecco-jcc/jjz041
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים